Clinical Trial Detail

NCT ID NCT03803553
Title Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Massachusetts General Hospital
Indications

colon adenocarcinoma

Therapies

Binimetinib + Cetuximab + Encorafenib

Nivolumab

Fluorouracil + Irinotecan + Leucovorin

Age Groups: senior adult

Additional content available in CKB BOOST